APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carbapenem

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Carbapenem Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchCarbapenem Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbapenem Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Carbapenem Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbapenem Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbapenem Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Carbapenem market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Carbapenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Carbapenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carbapenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Carbapenem market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Carbapenem market include Sun Pharmaceutical Industries, Pfizer, Haibin Pharmaceutical, United Lab, Savior Lifetec, Kopran and HISUN Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Carbapenem market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Carbapenem and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Carbapenem sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Carbapenem market size, projected growth trends, production technologies, key applications, and end-use industries.

Carbapenem Segment by Company

Sun Pharmaceutical Industries

Pfizer

Haibin Pharmaceutical

United Lab

Savior Lifetec

Kopran

HISUN Pharmaceutical

Carbapenem Segment by Type

Doripenem

Meropenem

Panipenem

Imipenem

Others

Carbapenem Segment by Application

Hosptials

Clinics

Others

Carbapenem Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Carbapenem status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Carbapenem market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Carbapenem significant trends, drivers, influence factors in global and regions.

6. To analyze Carbapenem competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbapenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbapenem and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbapenem.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Carbapenem market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Carbapenem industry.

Chapter 3: Detailed analysis of Carbapenem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Carbapenem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Carbapenem in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Carbapenem Industry Trends Table 2. Carbapenem Industry Drivers Table 3. Carbapenem Industry Opportunities and Challenges Table 4. Carbapenem Industry Restraints Table 5. Global Carbapenem Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Carbapenem Revenue Share by Company (2021-2026) Table 7. Global Carbapenem Sales Volume by Company (tons) & (2021-2026) Table 8. Global Carbapenem Sales Volume Share by Company (2021-2026) Table 9. Global Carbapenem Average Price (US$/kg) of Company (2021-2026) Table 10. Global Carbapenem Company Ranking, (2024-2026) & (USD Million) Table 11. Global Carbapenem Key Company Manufacturing Base & Headquarters Table 12. Global Carbapenem Company, Product Type & Application Table 13. Global Carbapenem Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Carbapenem by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Doripenem Table 18. Significant Companies of Meropenem Table 19. Significant Companies of Panipenem Table 20. Significant Companies of Imipenem Table 21. Significant Companies of Others Table 22. Global Carbapenem Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 23. Global Carbapenem Sales Volume by Type (2021-2026) & (tons) Table 24. Global Carbapenem Sales Volume by Type (2027-2032) & (tons) Table 25. Global Carbapenem Sales Volume Share by Type (2021-2026) Table 26. Global Carbapenem Sales Volume Share by Type (2027-2032) Table 27. Global Carbapenem Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Carbapenem Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Carbapenem Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Carbapenem Sales Value Share by Type (2021-2026) Table 31. Global Carbapenem Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hosptials Table 33. Significant Companies of Clinics Table 34. Significant Companies of Others Table 35. Global Carbapenem Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 36. Global Carbapenem Sales Volume by Application (2021-2026) & (tons) Table 37. Global Carbapenem Sales Volume by Application (2027-2032) & (tons) Table 38. Global Carbapenem Sales Volume Share by Application (2021-2026) Table 39. Global Carbapenem Sales Volume Share by Application (2027-2032) Table 40. Global Carbapenem Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Carbapenem Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Carbapenem Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Carbapenem Sales Value Share by Application (2021-2026) Table 44. Global Carbapenem Sales Value Share by Application (2027-2032) Table 45. Global Carbapenem Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 46. Global Carbapenem Sales by Region (2021-2026) & (tons) Table 47. Global Carbapenem Sales Market Share by Region (2021-2026) Table 48. Global Carbapenem Sales by Region (2027-2032) & (tons) Table 49. Global Carbapenem Sales Market Share by Region (2027-2032) Table 50. Global Carbapenem Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Carbapenem Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Carbapenem Sales Value Share by Region (2021-2026) Table 53. Global Carbapenem Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Carbapenem Sales Value Share by Region (2027-2032) Table 55. Global Carbapenem Market Average Price (US$/kg) by Region (2021-2026) Table 56. Global Carbapenem Market Average Price (US$/kg) by Region (2027-2032) Table 57. Global Carbapenem Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 58. Global Carbapenem Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Carbapenem Sales by Country (2021-2026) & (tons) Table 60. Global Carbapenem Sales Market Share by Country (2021-2026) Table 61. Global Carbapenem Sales by Country (2027-2032) & (tons) Table 62. Global Carbapenem Sales Market Share by Country (2027-2032) Table 63. Global Carbapenem Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Carbapenem Sales Value Market Share by Country (2021-2026) Table 65. Global Carbapenem Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Carbapenem Sales Value Market Share by Country (2027-2032) Table 67. Sun Pharmaceutical Industries Company Information Table 68. Sun Pharmaceutical Industries Business Overview Table 69. Sun Pharmaceutical Industries Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical Industries Carbapenem Product Portfolio Table 71. Sun Pharmaceutical Industries Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Pfizer Carbapenem Product Portfolio Table 76. Pfizer Recent Development Table 77. Haibin Pharmaceutical Company Information Table 78. Haibin Pharmaceutical Business Overview Table 79. Haibin Pharmaceutical Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. Haibin Pharmaceutical Carbapenem Product Portfolio Table 81. Haibin Pharmaceutical Recent Development Table 82. United Lab Company Information Table 83. United Lab Business Overview Table 84. United Lab Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. United Lab Carbapenem Product Portfolio Table 86. United Lab Recent Development Table 87. Savior Lifetec Company Information Table 88. Savior Lifetec Business Overview Table 89. Savior Lifetec Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Savior Lifetec Carbapenem Product Portfolio Table 91. Savior Lifetec Recent Development Table 92. Kopran Company Information Table 93. Kopran Business Overview Table 94. Kopran Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Kopran Carbapenem Product Portfolio Table 96. Kopran Recent Development Table 97. HISUN Pharmaceutical Company Information Table 98. HISUN Pharmaceutical Business Overview Table 99. HISUN Pharmaceutical Carbapenem Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. HISUN Pharmaceutical Carbapenem Product Portfolio Table 101. HISUN Pharmaceutical Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Carbapenem Distributors List Table 105. Carbapenem Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Carbapenem Product Image Figure 2. Global Carbapenem Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbapenem Sales Value (2021-2032) & (US$ Million) Figure 4. Global Carbapenem Sales (2021-2032) & (tons) Figure 5. Global Carbapenem Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Carbapenem Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Doripenem Image Figure 10. Meropenem Image Figure 11. Panipenem Image Figure 12. Imipenem Image Figure 13. Others Image Figure 14. Global Carbapenem Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 15. Global Carbapenem Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Carbapenem Sales Volume Share by Type (2021-2032) Figure 17. Global Carbapenem Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Carbapenem Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Carbapenem Sales Value Share by Type (2021-2032) Figure 20. Hosptials Image Figure 21. Clinics Image Figure 22. Others Image Figure 23. Global Carbapenem Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 24. Global Carbapenem Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Carbapenem Sales Volume Share by Application (2021-2032) Figure 26. Global Carbapenem Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Carbapenem Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Carbapenem Sales Value Share by Application (2021-2032) Figure 29. Global Carbapenem Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 30. Global Carbapenem Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Carbapenem Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Carbapenem Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Carbapenem Sales Value (2021-2032) & (US$ Million) Figure 34. North America Carbapenem Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Carbapenem Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Carbapenem Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Carbapenem Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Carbapenem Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Carbapenem Sales Value (2021-2032) & (US$ Million) Figure 40. South America Carbapenem Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Carbapenem Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Carbapenem Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Carbapenem Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Carbapenem Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Carbapenem Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Carbapenem Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Carbapenem Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Doripenem
  • Meropenem
  • Panipenem
  • Imipenem
  • Others
Applications
  • Hosptials
  • Clinics
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Pfizer
  • Haibin Pharmaceutical
  • United Lab
  • Savior Lifetec
  • Kopran
  • HISUN Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Carbapenem Sales Value (2021-2032)
  4. 1.2.2 Global Carbapenem Sales Volume (2021-2032)
  5. 1.2.3 Global Carbapenem Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Carbapenem Market Dynamics
  1. 2.1 Carbapenem Industry Trends
  2. 2.2 Carbapenem Industry Drivers
  3. 2.3 Carbapenem Industry Opportunities and Challenges
  4. 2.4 Carbapenem Industry Restraints
3 Carbapenem Market by Company
  1. 3.1 Global Carbapenem Company Revenue Ranking in 2025
  2. 3.2 Global Carbapenem Revenue by Company (2021-2026)
  3. 3.3 Global Carbapenem Sales Volume by Company (2021-2026)
  4. 3.4 Global Carbapenem Average Price by Company (2021-2026)
  5. 3.5 Global Carbapenem Company Ranking (2024-2026)
  6. 3.6 Global Carbapenem Company Manufacturing Base and Headquarters
  7. 3.7 Global Carbapenem Company Product Type and Application
  8. 3.8 Global Carbapenem Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Carbapenem Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Carbapenem Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Carbapenem Market by Type
  1. 4.1 Carbapenem Type Introduction
  2. 4.1.1 Doripenem
  3. 4.1.2 Meropenem
  4. 4.1.3 Panipenem
  5. 4.1.4 Imipenem
  6. 4.1.5 Others
  7. 4.2 Global Carbapenem Sales Volume by Type
  8. 4.2.1 Global Carbapenem Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Carbapenem Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Carbapenem Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Carbapenem Sales Value by Type
  12. 4.3.1 Global Carbapenem Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Carbapenem Sales Value by Type (2021-2032)
  14. 4.3.3 Global Carbapenem Sales Value Share by Type (2021-2032)
5 Carbapenem Market by Application
  1. 5.1 Carbapenem Application Introduction
  2. 5.1.1 Hosptials
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Carbapenem Sales Volume by Application
  6. 5.2.1 Global Carbapenem Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Carbapenem Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Carbapenem Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Carbapenem Sales Value by Application
  10. 5.3.1 Global Carbapenem Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Carbapenem Sales Value by Application (2021-2032)
  12. 5.3.3 Global Carbapenem Sales Value Share by Application (2021-2032)
6 Carbapenem Regional Sales and Value Analysis
  1. 6.1 Global Carbapenem Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Carbapenem Sales by Region (2021-2032)
  3. 6.2.1 Global Carbapenem Sales by Region: 2021-2026
  4. 6.2.2 Global Carbapenem Sales by Region (2027-2032)
  5. 6.3 Global Carbapenem Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Carbapenem Sales Value by Region (2021-2032)
  7. 6.4.1 Global Carbapenem Sales Value by Region: 2021-2026
  8. 6.4.2 Global Carbapenem Sales Value by Region (2027-2032)
  9. 6.5 Global Carbapenem Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Carbapenem Sales Value (2021-2032)
  12. 6.6.2 North America Carbapenem Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Carbapenem Sales Value (2021-2032)
  15. 6.7.2 Europe Carbapenem Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Carbapenem Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Carbapenem Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Carbapenem Sales Value (2021-2032)
  21. 6.9.2 South America Carbapenem Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Carbapenem Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Carbapenem Sales Value Share by Country, 2025 VS 2032
7 Carbapenem Country-level Sales and Value Analysis
  1. 7.1 Global Carbapenem Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Carbapenem Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Carbapenem Sales by Country (2021-2032)
  4. 7.3.1 Global Carbapenem Sales by Country (2021-2026)
  5. 7.3.2 Global Carbapenem Sales by Country (2027-2032)
  6. 7.4 Global Carbapenem Sales Value by Country (2021-2032)
  7. 7.4.1 Global Carbapenem Sales Value by Country (2021-2026)
  8. 7.4.2 Global Carbapenem Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Carbapenem Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Carbapenem Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Carbapenem Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Carbapenem Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Carbapenem Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Carbapenem Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Carbapenem Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Carbapenem Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Carbapenem Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Carbapenem Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Carbapenem Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Carbapenem Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Carbapenem Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Carbapenem Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Carbapenem Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Carbapenem Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Carbapenem Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Carbapenem Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Carbapenem Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Carbapenem Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Carbapenem Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Carbapenem Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Carbapenem Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Carbapenem Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Carbapenem Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Carbapenem Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Carbapenem Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Carbapenem Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Carbapenem Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Carbapenem Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Carbapenem Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Carbapenem Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Carbapenem Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Carbapenem Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Carbapenem Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Carbapenem Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Carbapenem Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Carbapenem Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Carbapenem Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Carbapenem Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Carbapenem Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Carbapenem Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Carbapenem Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Carbapenem Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Carbapenem Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Carbapenem Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Carbapenem Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Carbapenem Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Carbapenem Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Carbapenem Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Carbapenem Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Carbapenem Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Carbapenem Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Carbapenem Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Carbapenem Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Carbapenem Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Carbapenem Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Carbapenem Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Carbapenem Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Carbapenem Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Carbapenem Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Carbapenem Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Carbapenem Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Carbapenem Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Carbapenem Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Carbapenem Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Carbapenem Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Carbapenem Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Carbapenem Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Carbapenem Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Carbapenem Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Carbapenem Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Carbapenem Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Carbapenem Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Carbapenem Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Carbapenem Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Carbapenem Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Carbapenem Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Carbapenem Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Carbapenem Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Carbapenem Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Carbapenem Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Carbapenem Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Carbapenem Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Carbapenem Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Carbapenem Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Carbapenem Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Carbapenem Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Haibin Pharmaceutical
  14. 8.3.1 Haibin Pharmaceutical Company Information
  15. 8.3.2 Haibin Pharmaceutical Business Overview
  16. 8.3.3 Haibin Pharmaceutical Carbapenem Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Haibin Pharmaceutical Carbapenem Product Portfolio
  18. 8.3.5 Haibin Pharmaceutical Recent Developments
  19. 8.4 United Lab
  20. 8.4.1 United Lab Company Information
  21. 8.4.2 United Lab Business Overview
  22. 8.4.3 United Lab Carbapenem Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 United Lab Carbapenem Product Portfolio
  24. 8.4.5 United Lab Recent Developments
  25. 8.5 Savior Lifetec
  26. 8.5.1 Savior Lifetec Company Information
  27. 8.5.2 Savior Lifetec Business Overview
  28. 8.5.3 Savior Lifetec Carbapenem Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Savior Lifetec Carbapenem Product Portfolio
  30. 8.5.5 Savior Lifetec Recent Developments
  31. 8.6 Kopran
  32. 8.6.1 Kopran Company Information
  33. 8.6.2 Kopran Business Overview
  34. 8.6.3 Kopran Carbapenem Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kopran Carbapenem Product Portfolio
  36. 8.6.5 Kopran Recent Developments
  37. 8.7 HISUN Pharmaceutical
  38. 8.7.1 HISUN Pharmaceutical Company Information
  39. 8.7.2 HISUN Pharmaceutical Business Overview
  40. 8.7.3 HISUN Pharmaceutical Carbapenem Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 HISUN Pharmaceutical Carbapenem Product Portfolio
  42. 8.7.5 HISUN Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Carbapenem Value Chain Analysis
  2. 9.1.1 Carbapenem Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Carbapenem Sales Mode & Process
  6. 9.2 Carbapenem Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Carbapenem Distributors
  9. 9.2.3 Carbapenem Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst